FDA Approves Marketing Of Consumer Genetic Tests For Some Conditions

FDA Approves Marketing Of Consumer Genetic Tests For Some Conditions

NPR
Jessica Body
April 7, 2017

The U.S. Food and Drug Administration approved 23andMe's personal genetic test for some diseases on Thursday, including Alzheimer's, Parkinson's and Celiac disease.

The tests assess genetic risk for the conditions, but don't diagnose them, the FDA says. The agency urges consumers to use their results to "help to make decisions about lifestyle choices or to inform discussions with a health care professional," according to a press release about the decision.

 

Recent Stories
NSGC President Gillian Hooker Interviewed on Spark Podcast

NSGC Media Placements from Q4 2018

NSGC Responds to U.S. Food and Drug Administration Approval of Direct-to-Consumer Cancer Test that Reports Three BRCA Mutations

NSGC Executive Office   |   330 North Wabash Avenue, Suite 2000, Chicago, IL 60611   |   312.321.6834   |   nsgc@nsgc.org
© 2020 National Society of Genetic Counselors   |   Privacy Policy   |   Disclaimer   |   Terms and Conditions   |   DMCA Procedures for Removal